Desq Long
Sign in
SEC FORM 4
—

MiNK Therapeutics, Inc. (INKT)

Acquisition (code M) of 23,191 shares; price not stated (see filing).

Reporting Person Buell Jennifer · Officer Title Chief Executive Officer · Transaction Code M

Traded Oct 11, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001193125-26-421529 · filed 2026-10-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "MiNK Therapeutics, Inc. (INKT)." Disclosed 2026-10-14. https://desqlong.com/cards/0001193125-26-421529-1 (retrieved 2026-10-15).